Similar articles

• Re: Shapiro F, Zurakowski D, Sethna NF. Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusion for Duchenne muscular dystrophy scoliosis. Spine 2007;32:2278-83.

  Turturro F, Rocca B, Montanaro A. Turturro F, et al. Spine (Phila Pa 1976). 2008 Apr 1;33(7):827; author reply 827-8. doi: 10.1097/BRS.0b013e31816950c0. Spine (Phila Pa 1976). 2008. PMID: 18379414 No abstract available.
• The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.

  Gill JB, Rosenstein A. Gill JB, et al. J Arthroplasty. 2006 Sep;21(6):869-73. doi: 10.1016/j.arth.2005.09.009. J Arthroplasty. 2006. PMID: 16950041
• Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.

  Colomina MJ, Bagó J, Vidal X, Mora L, Pellisé F. Colomina MJ, et al. Orthopedics. 2009 Feb;32(2):91. Orthopedics. 2009. PMID: 19301800
• Antifibrinolytics.

  Schmarts. Schmarts. Acta Anaesthesiol Belg. 2003;54(4):319-22. Acta Anaesthesiol Belg. 2003. PMID: 14719353 Review. No abstract available.
• Indications and contraindications of cell salvage.

  Waters JH. Waters JH. Transfusion. 2004 Dec;44(12 Suppl):40S-4S. doi: 10.1111/j.0041-1132.2004.04176.x. Transfusion. 2004. PMID: 15585004 Review. No abstract available.